BioSpace News Archive

Genetown

VBI Vaccines Announces Multiple Abstracts Accepted for Poster Presentations at EASL 2021

VBI Vaccines Inc. today announced that two abstracts featuring data from the Company’s prophylactic and therapeutic hepatitis B (HBV) candidates have been accepted for presentation at The Digital International Liver Congress™ 2021.

June 9, 2021
·
6 min read
BioMidwest

Able Medical Announces First Surgeries and Launch of the Valkyrie™ Thoracic Fixation System

Able Medical Devices announces the recent launch of its Valkyrie™ Thoracic Fixation System, the market’s first single-use radiolucent plating system designed to span the osteotomy and close the sternum after open heart surgery.

June 9, 2021
·
2 min read
Biotech Bay

Oncology Pharma and Ribera Solutions Release White Paper Regarding Patient Engagement and Retention Platform

Oncology Pharma Inc. is releasing a White Paper outlining 5 innovative ways to improve patient engagement in clinical trials.

June 9, 2021
·
4 min read
Bold Therapeutics Receives Additional Funding to Support Development of BOLD-100 as a Novel Antiviral

Bold Therapeutics is pleased to announce that it is receiving advisory services and additional research and development funding of up to CAD$965,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).

June 9, 2021
·
3 min read
Business

Biocept and CLEARED4 Collaborate to Develop New Service for Managing COVID-19 Testing and Results Reporting for Biocept Customers

Integrated solution incorporates testing protocols and real-time test results to help ensure safer, healthier campuses, healthcare facilities and other venues.

June 9, 2021
·
6 min read
Drug Development

Omeros Announces Preliminary Results from Phase 1 Clinical Trial of OMS906

Omeros Corporation today announced preliminary results from the Phase 1 clinical trial of its MASP-3 inhibitor OMS906.

June 9, 2021
·
6 min read
Genetown

Echosens Launches New FibroScan-Based Scores Agile 3+ & Agile 4: Identifies Advanced Fibrosis and Cirrhosis, Predicts Clinical Outcomes, Improves Patient Management

Researchers present findings at EASL International Liver Congress™ 2021, June 23-26, 2021.

June 9, 2021
·
2 min read
Sunshine Biopharma Mice Study for COVID-19 Treatment Progressing as Planned

Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, confirmed that its COVID-19 mice study currently underway at the University of Georgia is progressing as planned.

June 9, 2021
·
4 min read
COPIKTRA® (duvelisib) Receives European Union Marketing Authorization for the Treatment of Relapsed or Refractory CLL and Refractory FL

Secura Bio, Inc. (Secura Bio) - (www.securabio.com), today announced that on May 19, 2021 the European Medicines Agency granted marketing authorization for COPIKTRA

June 9, 2021
·
7 min read
Genetown

Navigation Sciences™ Begins First-in-Human Clinical Feasibility Trial of its Pioneering, NaviSci™ System for Tissue-Conserving Removal of Early-Stage Lung Tumors

Navigation Sciences announced that the initial patient has participated in the first-in-human clinical feasibility trial of its NaviSci™ System for use in minimally invasive surgery to remove probable early-stage lung tumors.

June 9, 2021
·
3 min read